Fennec completes $7.6M private placement

On June 8, Fennec Pharmaceuticals Inc. (TSX:FRX; OTCQB:FENCF) raised $7.6 million through the sale of 1.9 million shares at $4 in a private placement to Essetifin and venBio Select Advisor and other investors...